# SADBE for Congenital Melanocytic Nevi

> **NCT04999631** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Congenital Melanocytic Nevus

## Interventions

- **DRUG:** Squaric Acid Dibutyl Ester
- **DRUG:** Ethanol Solution

## Key facts

- **NCT ID:** NCT04999631
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04999631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04999631, "SADBE for Congenital Melanocytic Nevi". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04999631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*